AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The single use Uretero1™ Ureteroscope System is intended to visualize organs, cavities and canals in the urinary tract (urethra, bladder, ureter, calyces and renal papillae) via transurethral or percutaneous access routes. It can also be used in conjunction with endoscopic accessories to perform various diagnostic and therapeutic procedures in the urinary tract.

Device Description

The Uretero1™ Ureteroscope System contains an all-in-one camera control unit (CCU) for image processing and display. The CCU operates at 110 V - 230V ~ 50 - 60 Hz and has a simple graphical user interface that prompts the clinician through actions to get a live view via the Ureteroscope. After unpackaging the sterile, single-use ureteroscope, the user is required to plug in the single-use ureteroscope device via a 16-pin male connector inserted into the CCU to obtain a live image. There is a process of authentication, in which the CCU recognizes the firmware of the inserted product, and the image from the ureteroscope is displayed on live view. The Uretero1™ CCU software platform is based on i.MX8MQ processor from NXP and LATTICE ECP5 FPGA. The ECP5 provides the camera interface plus ISP functionality. The CCU software is based on Linux board support package provided by NXP. The board support package and Linux distribution are configured and built using YOCTO. The main functionality of the system is to capture the video from an external camera and display it to an external display. Graphical user interface is developed using QT5. Video pipeline is implemented through g-streamer.

The ureteroscope is disposable and can be utilized for up to 4 hours. The ureteroscope possesses a 4-hour countdown timer and after 4 hours of usage, the ureteroscope will no longer produce a live image and a use notification message will be displayed on the screen informing the user that the ureteroscope usage time has expired. The ureteroscope has 3 use notification messages. One occurs at 60 minutes left on the timer and appears on the side menu bar of the display screen on the CCU. A second occurs with 30 minutes left on the timer and also appears on the side menu bar. The final notification message appears with 5 minutes of time remaining on the ureteroscope and it is in the middle of the screen and requires user interaction to acknowledge the use notification message by pressing OK. When the duration of time has elapsed, the ureteroscope will no longer produce a live image and the user will be directed to a screen that states the ureteroscope no longer has any usable time remaining and to insert new ureteroscope.

Once the flexible shaft is inserted into the patient, the distal tip is steered via the articulation lever on the ureteroscope handle. The flexible shaft allows for passive secondary deflection while accessing the patient's urinary tract. The flexible shaft contains a working channel to allow surgical accessories and procedural solutions to be delivered through the distal tip to the surgical field. The handle button allows the user to take photos, record video and zoom in and out. In addition to the articulation lever and the handle button, the handle contains an accessory access port and a connection port for procedural solutions. An irrigation system (irrigation tubing and an irrigation source) can be attached to one port and the biopsy port cover can be attached to the other port. In this way, the user can use endoscopic instruments through the biopsy port cover and irrigate at the same time. The Uretero1TM Single-Use Digital Flexible Ureteroscope must be used in conjunction with the Vision1™ Imaging Console and Display System (CCU).

In addition to image processing, the CCU supports video connectivity in two additional ways. The user is allowed to mirror image from the CCU to an external display which produces the same image the user sees on the CCU screen on any other compatible display system that accepts HDMI input. In addition, the CCU can accept an HDMI input signal from an external HDMI output and the CCU can act as a dummy display panel for the external HDMI imaging source. There are two USB data ports to provide data export (photos and video taken during procedure) or allow connection of selected accessories (printer). No data, including Electronic Protected Health Information (ePHI) data is stored on this device (e.g., last name, SSN, DOB, MRN) and there is no ethernet, Wi-Fi or Blue Tooth capability.

The ureteroscope will be offered in two different models: UreterolTM Ureteroscope (Standard Deflection) and Uretero1TM Ureteroscope (Reverse Deflection). To save procedural photo or video, a proprietary system encrypted USB drive is provided to Customers with the purchase of the CCU. The Vision1™ Imaging Console and Display System communicate with the encrypted USB drive, the Uretero1TM Single-Use Digital Flexible Ureteroscope, and the external printer.

The Uretero1 Ureteroscope System comes packaged with single-use, disposable accessory port cover. The accessory port cover is adjustable and is intended to resist the backflow of fluid around an instrument inserted through the working channel of the ureteroscope. It is designed to facilitate the passage of instruments during a procedure. It has a cap feature to allow instruments to be inserted and secured. A clicking mechanism is used to facilitate the open, semi-closed and closed position of the valve. It also has a side arm y-port with a luer cap to allow for irrigation or other procedural solutions, if needed. This accessory attaches to the instrument port of the Uretero1 Ureteroscope via a distal luer connection.

AI/ML Overview

I am sorry, but based on the provided text, there is no information about acceptance criteria or a study that proves the device meets specific performance criteria. The document is primarily an FDA 510(k) clearance letter and a summary of the device's technical characteristics and comparison to a predicate device.

The "Summary of Non-Clinical Performance Testing" table on page 9 mentions "Functional and Regression Testing," "Optical Color Performance Testing," and "White Balance Testing" all with "Pass" results, but it does not provide:

  • Specific quantifiable acceptance criteria (e.g., "accuracy greater than 90%").
  • Reported device performance values that can be compared against such criteria.
  • Details on the study methodology (e.g., sample size, data provenance, expert involvement, ground truth methods, MRMC studies, or training set information).

Therefore, I cannot fulfill your request to describe the acceptance criteria and the study that proves the device meets those criteria, as the necessary information is not present in the provided text.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logos of the Department of Health and Human Services and the Food and Drug Administration (FDA). The Department of Health and Human Services logo is on the left, and the FDA logo is on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.

July 25, 2023

STERIS Corporation Carroll Martin Regulatory Affairs Director 5976 Heislev Road Mentor, OH 44060

Re: K231878

Trade/Device Name: Uretero1TM Ureteroscope System Regulation Number: 21 CFR§ 876.1500 Regulation Name: Endoscope and Accessories Regulatory Class: II Product Code: FGB Dated: June 23, 2023 Received: June 26, 2023

Dear Carroll Martin:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.

{1}------------------------------------------------

You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatoryinformation/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Mark J. Antonino -S

Mark J. Antonino, M.S. Assistant Director DHT3B: Division of Reproductive. Gynecology and Urology Devices OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K231878

Device Name Uretero1TM Ureteroscope System

Indications for Use (Describe)

The single use Uretero1™ Ureteroscope System is intended to visualize organs, cavities and canals in the urinary tract (urethra, bladder, ureter, calyces and renal papillae) via transurethral or percutaneous access routes. It can also be used in conjunction with endoscopic accessories to perform various diagnostic and therapeutic procedures in the urinary tract.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

Image /page/3/Picture/0 description: The image shows the word "STERIS" in a large, bold, sans-serif font. Below the word "STERIS" is a graphic of several horizontal, wavy lines in blue. The lines are stacked on top of each other, creating a visual effect of water or waves. The STERIS logo is a registered trademark symbol.

K231878

Page 1 of 7

510(k) Summary for the Uretero1™ Ureteroscope System

STERIS Corporation 5960 Heisley Road Mentor, OH 44060

Contact:Carroll Martin
Regulatory Affairs Director
Tel: 440-358-6259
Email: Carroll_Martin@steris.com
Submission Date:July 19, 2023
510(k) :K231878

STERIS Corporation ■ 5960 Heisley Road ■ Mentor, OH 44060-1834 USA ■ 440-354-2600

{4}------------------------------------------------

1. Device Name

Trade Name:Uretero1™ Ureteroscope System
Device Class:Class II
Regulation Name:Endoscope and Accessories
Common/usual Name:Ureteroscope
Regulation Number:21 CFR 876.1500
Product Code:FGB

2. Predicate Device

Uretero1 Ureteroscope System, K223466 Class II (21 CFR 876.1500), product code FGB

Device Description 3.

The Uretero1™ Ureteroscope System contains an all-in-one camera control unit (CCU) for image processing and display. The CCU operates at 110 V - 230V ~ 50 - 60 Hz and has a simple graphical user interface that prompts the clinician through actions to get a live view via the Ureteroscope. After unpackaging the sterile, single-use ureteroscope, the user is required to plug in the single-use ureteroscope device via a 16-pin male connector inserted into the CCU to obtain a live image. There is a process of authentication, in which the CCU recognizes the firmware of the inserted product, and the image from the ureteroscope is displayed on live view. The Uretero1™ CCU software platform is based on i.MX8MQ processor from NXP and LATTICE ECP5 FPGA. The ECP5 provides the camera interface plus ISP functionality. The CCU software is based on Linux board support package provided by NXP. The board support package and Linux distribution are configured and built using YOCTO. The main functionality of the system is to capture the video from an external camera and display it to an external display. Graphical user interface is developed using QT5. Video pipeline is implemented through g-streamer.

The ureteroscope is disposable and can be utilized for up to 4 hours. The ureteroscope possesses a 4-hour countdown timer and after 4 hours of usage, the ureteroscope will no longer produce a live image and a use notification message will be displayed on the screen informing the user that the ureteroscope usage time has expired. The ureteroscope has 3 use notification messages. One occurs at 60 minutes left on the timer and appears on the side menu bar of the display screen on the CCU. A second occurs with 30 minutes left on the timer and also appears on the side menu bar. The final notification message appears with 5 minutes of time remaining on the ureteroscope and it is in the middle of the screen and requires user interaction to acknowledge the use notification message by pressing OK. When the duration of time has elapsed, the ureteroscope will no longer produce a live image and the user will be directed to a screen that states the ureteroscope no longer has any usable time remaining and to insert new ureteroscope.

Once the flexible shaft is inserted into the patient, the distal tip is steered via the articulation lever on the ureteroscope handle. The flexible shaft allows for passive secondary deflection while accessing the patient's urinary tract. The flexible shaft contains a working channel to allow surgical accessories and procedural solutions to be delivered through the distal tip to the surgical field. The handle button allows the user to take photos, record video and zoom

{5}------------------------------------------------

in and out. In addition to the articulation lever and the handle button, the handle contains an accessory access port and a connection port for procedural solutions. An irrigation system (irrigation tubing and an irrigation source) can be attached to one port and the biopsy port cover can be attached to the other port. In this way, the user can use endoscopic instruments through the biopsy port cover and irrigate at the same time. The Uretero1TM Single-Use Digital Flexible Ureteroscope must be used in conjunction with the Vision1™ Imaging Console and Display System (CCU).

In addition to image processing, the CCU supports video connectivity in two additional ways. The user is allowed to mirror image from the CCU to an external display which produces the same image the user sees on the CCU screen on any other compatible display system that accepts HDMI input. In addition, the CCU can accept an HDMI input signal from an external HDMI output and the CCU can act as a dummy display panel for the external HDMI imaging source. There are two USB data ports to provide data export (photos and video taken during procedure) or allow connection of selected accessories (printer). No data, including Electronic Protected Health Information (ePHI) data is stored on this device (e.g., last name, SSN, DOB, MRN) and there is no ethernet, Wi-Fi or Blue Tooth capability.

The ureteroscope will be offered in two different models: UreterolTM Ureteroscope (Standard Deflection) and Uretero1TM Ureteroscope (Reverse Deflection). To save procedural photo or video, a proprietary system encrypted USB drive is provided to Customers with the purchase of the CCU. The Vision1™ Imaging Console and Display System communicate with the encrypted USB drive, the Uretero1TM Single-Use Digital Flexible Ureteroscope, and the external printer.

The Uretero1 Ureteroscope System comes packaged with single-use, disposable accessory port cover. The accessory port cover is adjustable and is intended to resist the backflow of fluid around an instrument inserted through the working channel of the ureteroscope. It is designed to facilitate the passage of instruments during a procedure. It has a cap feature to allow instruments to be inserted and secured. A clicking mechanism is used to facilitate the open, semi-closed and closed position of the valve. It also has a side arm y-port with a luer cap to allow for irrigation or other procedural solutions, if needed. This accessory attaches to the instrument port of the Uretero1 Ureteroscope via a distal luer connection.

4. Indications for Use

The single use Uretero1™ Ureteroscope System is intended to be used to visualize organs, cavities and canals in the urinary tract (urethra, bladder, ureter, calyces and renal papillae) via transurethral or percutaneous access routes. It can also be used in conjunction with endoscopic accessories to perform various diagnostic and therapeutic procedures in the urinary tract.

{6}------------------------------------------------

5. Comparison of Technological Characteristics with the Predicate Device

A comparison of technical characteristics between the proposed and predicate devices is summarized in Table 1.

FeaturesUretero1™ UreteroscopeSystem K223466Uretero1™ UreteroscopeSystem Modified DeviceComparison
Intended UseThe single use Uretero1™Ureteroscope System isintended to be used to visualizeorgans, cavities and canals inthe urinary tract (urethra,bladder, ureter, calyces andrenal papillae) via transurethralor percutaneous access routes. Itcan also be used in conjunctionwith endoscopic accessories toperform various diagnostic andtherapeutic procedures in theurinary tract.The single use Uretero1™Ureteroscope System isintended to be used to visualizeorgans, cavities and canals inthe urinary tract (urethra,bladder, ureter, calyces andrenal papillae) via transurethralor percutaneous access routes.It can also be used inconjunction with endoscopicaccessories to perform variousdiagnostic and therapeuticprocedures in the urinary tract.Identical
UreteroscopeConstruction /ComponentsHandleArticulation LeverHandle ButtonAccessory PortIrrigation PortConnector CableConnector Cable PlugFlexible ShaftArticulation SectionDistal Tip (camera, illuminationoptics, and the working channel,video signal cables, articulationwires and light fiber)Instrument ChannelLight (illumination fiber)CameraHandleArticulation LeverHandle ButtonAccessory PortIrrigation PortConnector CableConnector Cable PlugFlexible ShaftArticulation SectionDistal Tip (camera, illuminationoptics, and the working channel,video signal cables, articulationwires and light fiber)Instrument ChannelLight (illumination fiber)CameraIdentical
Monitor ComponentsFrameTouchscreen with AntiglareUSB PortsScope ConnectorPower ButtonHDMI InHDMI OutUSB Type B PortAD/DC Power CableFrameTouchscreen with AntiglareUSB PortsScope ConnectorPower ButtonHDMI InHDMI OutUSB Type B PortAD/DC Power CableIdentical
Sterile/Non-sterileSterileSterileIdentical
Sterilization MethodEthylene OxideEthylene OxideIdentical
Sterilization AssuranceLevel10-610-6Identical
UsageSingle use, disposableSingle use, disposableIdentical
FeaturesUretero1™ UreteroscopeSystem K223466Uretero1™ UreteroscopeSystem Modified DevicePageComparison
FunctionalityIrrigation capability throughirrigation portAbility to use endoscopic toolsthrough instrument portAbility to record images (pictureand video)Ability to record to externalmedia (USB flash)Audio (notifications to the user)Irrigation capability throughirrigation portAbility to use endoscopic toolsthrough instrument portAbility to record images (pictureand video)Ability to record to externalmedia (USB flash)Audio (notifications to the user)Identical
Ureteroscope WorkingDistance2mm – 50mm2mm – 50mmIdentical
DimensionsTip Diameter: 6.6F (2.2mm)Outer Diameter: 9.5F (3.2mm)Instrument Channel internaldiameter: 3.6F (1.2mm)Tip Diameter: 6.6F (2.2mm)Outer Diameter: 9.5F (3.2mm)Instrument Channel internaldiameter: 3.6F (1.2mm)Identical
Ureteroscope TipDeflection270° in both directions270° in both directionsIdentical
Target PopulationPatients undergoing a urologicalendoscopic procedurePatients undergoing a urologicalendoscopic procedureIdentical
Energy Used/DeliveredNoneNoneIdentical
Accessories ProvidedAccessory port coverAccessory port coverIdentical
Method of ApplicationManualManualIdentical
Software SystemThe Uretero1™ CCU softwareplatform is based on i.MX8MQprocessor from NXP andLATTICE ECP5 FPGA. TheECP5 provides the camerainterface plus ISP functionality.The CCU software is based onLinux board support packageprovided by NXP. The boardsupport package and Linuxdistribution are configured andbuilt using YOCTO. The mainfunctionality of the system is tocapture the video from anexternal camera and display it toan external display. Graphicaluser interface is developed usingQT5. Video pipeline isimplemented through g-streamer.The Uretero1™ CCU softwareplatform is based on i.MX8MQprocessor from NXP andLATTICE ECP5 FPGA. TheECP5 provides the camerainterface plus ISP functionality.The CCU software is based onLinux board support packageprovided by NXP. The boardsupport package and Linuxdistribution are configured andbuilt using YOCTO. The mainfunctionality of the system is tocapture the video from anexternal camera and display it toan external display. Graphicaluser interface is developed usingQT5. Video pipeline isimplemented through g-streamer.Identical
Printer CompatibleYesYesIdentical
Expiration Date3 years3 yearsIdentical
FeaturesUreterol™ UreteroscopeSystem K223466Ureterol™ Ureteroscope SystemModified DeviceComparison
Software UpdateUpdate the software toincrease the number ofqueries to the imagesensor (5 - 50).Only 5 queries made to theimage sensor when thescope is first plugged in50 queries made to theimage sensor when thescope is first plugged in.Similar. Queries to theimage sensor are still madewhen the scope is firstplugged in but increasingthe number from 5 to 50improves ISP bootreliability. This change hasno impact on safety,effectiveness or how thedevice is used.
Software UpdateUpdate to the softwareto allow it to read thecalibration data of thelumen output of thescope LED.The software in thepredicate could not read thecalibration data.The software in thesubject device can readthe calibration data.Different. This featureallows the lumencalibration algorithm to usethe calibration data storedon the ureteroscope toachieve a targetillumination level, therebyachieving consistentperformance acrossdifferent ureteroscopes.This change has no impacton safety, effectiveness orhow the device is used.
Software UpdateUpdate the software toreturn the default LEDcurrent to 400mAThe software in thepredicate could not addressthe issue of the default LEDcurrent.The software in thesubject device has theability to return thedefault LED current to400mADifferent. This change isintended to return thedevice to its original designspecification. This changehas no impact on safety,effectiveness or how thedevice is used.
Software UpdateUpdate the software toset the default LEDbrightness from 70% to40%.Default LED brightness setat 70%Default LED brightnessset at 40%Different. This change wasimplemented due tocustomer preference. Thischange has no impact onsafety, effectiveness or howthe device is used.
Software UpdateUpdate the software toaddress a yellowingeffectA yellowing effect occurredon the device monitor.A yellowing effect doesnot occur on the devicemonitorDifferent. This change wasimplemented because ayellowing effect occurredwith the predicate device ininstances of a highconcentration of red objects(blood). The removal of theyellowing effect is acustomer preference. Thischange has no impact onsafety, effectiveness or howthe device is used.

Table 1. Technological Characteristics Comparison Table

{7}------------------------------------------------

{8}------------------------------------------------

{9}------------------------------------------------

6. Summary of Non-Clinical Performance Testing

Change TypeTesting TypeResultsStandardFDA Guidance
SoftwareFunctional andRegression TestingPassES60601-1:2005/(R)2012& A1:2012,C1:2009/(R)2012 &A2:2010/(R)2012 (Cons.Text) [Incl. AMD2:2021]Not applicable
Optical ColorPerformance TestingPassNot applicableNot applicable
White Balance TestingPassNot applicableNot applicable

Non-clinical testing consisted of the following:

7. Conclusion

Based on the intended use, technological characteristics and non-clinical performance data, the subject device is as safe and effective as and substantially equivalent to the legally marketed predicate device (K223466).

§ 876.1500 Endoscope and accessories.

(a)
Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification —(1)Class II (special controls). The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.